Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). The FMT group also showed a significant reduction in urinary 5-hydroxyindoleacetic acid (5-HIAA) levels from 8.6 to 7.32 mg/L (p = 0.022), while other metabolites showed no significant changes.…”

Video5_Aging, not Parkinson’s disease, decreases a recalibration of body ownership caused by vision-respiratory interaction.MP4 by Daiki Shoji (18283906)

Decreased expression of 5-HT_2A receptors but not of PSD-95 in spinal cord of carrageenan-injected rats. by Anne-Sophie Wattiez (460341)

DataSheet_1_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx by Qinggan Ni (14835463)

“…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …”

EMBS-treated cells undergo apoptosis correlated with decreased cell viability, metabolic activity and mitochondrial membrane potential. by Michelle Helen Visagie (3927308)

HvPIN1a localisation is influenced by BFA and its expression is decreased by cytokinin. by Gwendolyn K. Kirschner (5142644)

S5 Table - by Mohamad Karaky (8910497)

Subjects:

Average step length and frequency (± SEM) per 5% of the distance during normal and 3, 4, and 5 kg assisted 60 m sprints for men and women. by Roland van den Tillaar (6407390)

Effect of thalidomide on expression and cellular localization of CUL5 in control RAMEC and RAMEC transfected with ^S730ACUL5. by Bryan Kunkler (5204327)

Annexin A2 accumulates in the nucleus and decreases in the cytoplasm in response to genotoxic agents. by Patricia A. Madureira (114480)

Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)

Fig 7 - by Kalman F. Szucs (19353218)

Subjects:

Vaginal impedance values measured with the estrus cycle monitor before and after 7 days of cetrorelix treatment (Fig 2). by Kalman F. Szucs (19353218)

Subjects:

Maximum values of power spectrum density in 2 different groups of rats detected by in vivo smooth muscle electromyography (Fig 4). by Kalman F. Szucs (19353218)

Subjects:

The average radiant efficiency values in equally sized regions of interest of the non-pregnant uterus in the control and cetrorelix treated rats (Fig 6). by Kalman F. Szucs (19353218)

Subjects:

Inner medullary expression of the V2 vasopressin receptor. by Sophie Constantin Lütken (689916)

Subjects:

Average radiant efficiency (± SEM) in equally sized regions of interest (ROIs) of the non-pregnant uterus. by Kalman F. Szucs (19353218)

Subjects:

Vaginal impedance (± SEM) values measured with the estrus cycle monitor. by Kalman F. Szucs (19353218)

Subjects:

Effects of cetrorelix treatment on changes in the KCl-evoked contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Subjects:

Effects of cetrorelix treatment on changes in spontaneous contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Subjects: